Results 161 to 170 of about 51,904 (226)

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico, Marta Gutiérrez Pascual, María Dolores Caro Gutiérrez, Cristina Marcos Rodríguez, Javier de Quadros Malagón, Francisco Javier Vicente Martín   +5 more
wiley   +1 more source

Starspots as the origin of ultrafast drifting radio bursts from an active M dwarf. [PDF]

Sci Adv
Zhang J, Tian H, Bellotti S, Cang T, Callingham JR, Vedantham HK, Chen B, Yu S, Zarka P, Louis CK, Jiang P, Lu H, Gao Y, Sun J, Gan H, Li H, Sun C, Lei Z, Huang M.   +18 more
europepmc   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou, Sharon Edwards, Andrew Affleck   +2 more
wiley   +1 more source

Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease. [PDF]

Dermatopathology (Basel)
Fadel A, Nithura J, Saadoon ZF, Naseer L, Lopez-Lacayo A, Rojas Solano LE, Palau Morales C, Hernandez RJ, Hussain H.   +8 more
europepmc   +1 more source

Surgical Procedures and Medical Treatments Among Patients With Hidradenitis Suppurativa Before and After Referral to Specialised Dermatological Hospital Care: A Nationwide Registry Study

JEADV Clinical Practice, EarlyView.
Hidradenitis suppurativa (HS) is often diagnosed late, complicating management. In this nationwide Danish study including 10,196 patients with dermatologist‐verified HS, we examined treatment patterns before and after referral to specialised hospital care.
Nana A. L. Rosenø, Nadja Højgaard Pedersen, Yvonne Geissbühler, Nikolaj Holgersen, Valdemar Wendelboe Nielsen, Jacob P. Thyssen, Alexander Egeberg, Hans Christian Ring, Simon Francis Thomsen   +8 more
wiley   +1 more source

Clinical and imaging characteristics of neuroretinitis secondary to cat scratch disease from tertiary centers in Malaysia: a retrospective study. [PDF]

J Ophthalmic Inflamm Infect
Rajan RS, Kuganasan S, Ali NS, Aziz RAA, Mohamed SO.   +4 more
europepmc   +1 more source

Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis (PsO) and dermatomyositis (DM) are both autoimmune‐mediated, inflammatory conditions. The concurrence of PsO and DM is rare, and literature on their relationship remains limited. Additionally, cutaneous DM can be challenging to clinically diagnosis, often presenting with psoriasiform clinical features.
Emily R. Gordon, Karishma S. Shah, Sidharth Chand, Bonnie Lee, Janellen Smith, Michelle S. Min   +5 more
wiley   +1 more source

A young progenitor for the most common planetary systems in the Galaxy. [PDF]

Nature
Livingston JH, Petigura EA, David TJ, Masuda K, Owen J, Nesvorný D, Batygin K, de Leon J, Mori M, Ikuta K, Fukui A, Watanabe N, Orell Miquel J, Murgas F, Parviainen H, Korth J, Libotte F, Abreu García N, Gallardo PPM, Narita N, Pallé E, Tamura M, Yonehara A, Ridden-Harper A, Bieryla A, Trani AA, Mamajek EE, Ciardi DR, Gorjian V, Hillenbrand LA, Rebull LM, Newton ER, Mann AW, Vanderburg A, Stefánsson G, Mahadevan S, Cañas C, Ninan J, Higuera J, Todorov K, Désert JM, Pino L.   +41 more
europepmc   +1 more source

Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin, Tracey Brown‐Maher, Hélène Veillette, David O. Croitoru, Kyle Cullingham   +4 more
wiley   +1 more source

Systemic lupus pregnancies are characterized by an intrinsic pro-inflammatory monocyte transcriptome, driven by an aberrant miRNA signature. [PDF]

J Transl Autoimmun
Scherlinger M, Schmauch E, Carapito R, Pichot A, Alsaleh G, Paul N, Molitor A, Lefebvre F, Schmidt-Mutter C, Bahram S, Sibilia J, Georgel P.   +11 more
europepmc   +1 more source